Wave Eye Scouting 2020 Sip Club . . . "China's pharmaceutical retail enterprises in 2019-2020.

On August 14th, the "2019-2020 Comprehensive Competitiveness Ranking of China's Pharmaceutical Retail Enterprises" was announced.
all the listed companies won the 2020 Sipkin Award.
In order to match the increasing concentration of industry, meet the needs of market competition, and more objectively evaluate the chain competitive strength of different development states, Zhongkang Information 2020 China Pharmaceutical Retail Enterprise Comprehensive Competitiveness Rankings (hereinafter referred to as the Top 100 List) on the basis of the seven competitive forces, according to the layout of enterprise stores to be classified and selected.
distribution of stores is greater than or equal to 10 provinces, and a single province's turnover contribution does not exceed 70%, for the national layout chain.
the distribution of stores is greater than or equal to 3 provinces, and the turnover contribution of a single province does not exceed 80%, for cross-regional chains;
Hunan and Guangdong top 100 enterprises in 2019-2020 the largest number of enterprises in 28 provinces, autonomous regions and municipalities directly under the Central Government, of which Hunan, Guangdong ranked first, the largest number of enterprises on the list, reached 9;
the economic level and medical insurance policy are important factors affecting the development of local drug retailing, and the economically developed region is the main gathering area of the top 100 chains.
2019 sales reached more than 300 million yuan, up from 250 million yuan in 2018, the threshold on the list has been raised.
100 chains, the national layout chain 8, cross-regional chain 11, regional chain 81.
further increase in industrial concentration, the market share of the top 100 more than 40% in 2019 head chain expansion rate although slowed down, but the concentration of the top 100 chain market remains on the rise.
2019, the total number of direct stores in the top 100 chains reached 82,741, accounting for 15.8% of the country's total sales reached 186.3 billion yuan, accounting for 40.9% of the country's drug retail market share, up 3 percentage points from 2018.
average single-store output of the top 100 chains is 2.59 times the industry average.
while industrial concentration continues to rise, the polarization of the top 100 chains is being more and more obvious.
top 10 stores accounted for 44.4% of the top 100 stores and 46.8% of sales.
addition, the gap between the top 100 chain sales scale further widened, sales of the top 10 chain sales scale is 26.5 times the last 10, the stronger the stronger.
leading chain high-speed development, store expansion-driven head chain still maintains the expansion trend, but compared with the past extensive mergers and acquisitions expansion, the head chain into the endo-development period, the expansion of stores more self-opened or joined the way.
the head chain's growth in the number of stores and sales growth in 2019 to maintain the industry's leading position.
the top five listed chains added more than 500 stores, sales growth rate of more than 100 chains overall level of 13%.
2019, the expansion of leading chains across regions will be available.
the number of stores in Gansu and Zhang Zhongjing, Henan Province, will increase by more than 500 in 2019, similar to the number of single-hearted and ordinary people.
, Jianjia, Shuyu civilian, Tiantian and other chains are stepping up the pace of listing.
part of the high-density layout of the regional leading chain and Internet giants occurred "marriage", Ali Health has invested in Guizhou a tree, Shuyu civilian, Anhui Guosheng, Gansu DeshengTang and other regional leading chains.
in terms of operating efficiency, the top 100 chains in 2019 average daily effect of 48 yuan / square.
in the listed chain, the highest daily average effect is dassin forest, reaching 86 yuan / square, followed by the people's big pharmacy, leading enterprises to maintain the advantage of operating efficiency.
addition to the ordinary people's daily average Ping effect increased by 7 yuan / square, the four major listed chains daily average Ping effect change is not obvious.
the expansion of the sales scale of leading enterprises is mainly driven by new stores, and the improvement of store operating efficiency is the main problem that enterprises face after expansion.
scale expansion non-sustainable development, differentiated competition to seize the market with the normal operation of drug collection, medical insurance, drug supervision, taxation and other regulatory strengthening, retail pharmacies face the impact of falling prices, commodity profit model conversion, operating costs and other challenges.
expansion of our stores is no longer fully positively related to the sustainability of our business, and how to achieve a new balance needs to be rethinked.
traditional pharmacy chains and new DTP pharmacies are actively working in the face of huge market expectations from prescription outflows.
because of the specificity of the product, DTP pharmacies have a higher industry standard, leading the development of the retail terminal prescription drug market.
head chain and with the background of drug circulation chain, by virtue of industrial resources and customer resources advantages, walking in the forefront of the development of DTP business.
the relevant national policies to support the development of "Internet plus health care", online and offline integration is the trend of new retail pharmacies.
outbreak, so that the value of the pharmaceutical e-commerce business more prominent, great potential.
because of the large differences in online and offline operations, the current physical pharmacy chain enterprises of pharmaceutical e-commerce business is not rival to the Internet platform.
against the background of deepening the new medical reform and encouraging the development of Chinese medicine by the regulatory authorities, Chinese medicine specialty management enterprises provide consumers with a health service system combining medical care through the development of Chinese medicine.
has the traditional Chinese medicine old brand chain more brand advantages, in the Chinese medicine market competition is unique.
top 100 chains are the benchmark of the pharmaceutical retail industry in terms of size, consumer resources and efficiency of operation and management, and their influence is increasing with the increase of market concentration.
industry and the top 100 chain of cooperation, the market effect will be relatively prominent.
.